Scinai Immunotherapeutics Ltdis A Biopharmaceutical Company Based In Jerusalemisraelfounded In 2003 And Formerly Known As Biondvax Pharmaceuticals Ltd Scinai Focuses On Developingmanufacturingand Commercializing Biological Products Aimed At Treating Infectious And Autoimmune Diseasesthe Company Emphasizes Inflammation And Immunology Products And Operates A Boutique Contract Development And Manufacturing Organizationcdmothrough Its Scinai Bio Services Unit Scinai S Product Pipeline Features Innovative Nanosized Antibodiesnanoabstargeting Various Conditionsincluding Autoimmune Diseases Like Psoriasis And Asthmaas Well As Therapeutic And Prophylactic Applications For Covid 19The Company Collaborates With Esteemed Institutions Such As The Max Planck Society And The University Medical Center Ga Ttingen To Advance Its Research And Product Developmentscinai Also Provides Comprehensive Cdmo Services To Pharmaceutical And Biotech Companiesleveraging Its Expertise In Recombinant Protein Process Development And Cgmp Manufacturing
